Phase I/II Study of Genasense in Patients With Chronic Lymphocytic Leukemia

Completed · Phase 1/Phase 2

Conditions studied: Chronic Lymphocytic Leukemia, CLL

In brief

This non-randomized study will test the safety and effectiveness of Genasense in patients with CLL.

Key facts

Study ID

NCT00021749

Run by

Genta Incorporated

People needed

40

Starts

2001-01-01

Last updated by the study team

2009-11-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Long Island Jewish Medical Center — New Hyde Park, New York, United States
• MD Anderson Cancer Center — Houston, Texas, United States
• San Antonio Cancer Institute — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.